Pelthos Therapeutics, Inc. (PTHS)
25.20
+2.46
(+10.82%)
USD |
NYAM |
Apr 08, 11:38
Pelthos Therapeutics EPS Diluted (Quarterly) : -6.868 for Dec. 31, 2025
EPS Diluted (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
EPS Diluted (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
EPS Diluted (Quarterly) Benchmarks
| Lifecore Biomedical, Inc. | -0.2458 |
| Ligand Pharmaceuticals, Inc. | 2.119 |
| InspireMD, Inc. | -0.1428 |
| CytomX Therapeutics, Inc. | -0.1734 |
| Cibus, Inc. | -0.5886 |
EPS Diluted (Quarterly) Related Metrics
| Net Income (Quarterly) | -21.66M |
| Revenue (Quarterly) | 9.389M |
| Total Expenses (Quarterly) | 31.05M |
| Enterprise Value | 31.80M |
| Gross Profit Margin (Quarterly) | 69.23% |
| Profit Margin (Quarterly) | -230.7% |
| Earnings Yield | -88.35% |
| Normalized Earnings Yield | -73.94 |